Hexa Tradex

NSE: HEXATRADEXBSE: 534328
Compare with peers
₹ 148.00▼ 0.89 (−0.6%)29 Oct, 03:29 pm IST
Market cap
₹ 900 Cr.
P/E
41.4x
P/B
0.18x
52-week range
138 – 180.55
ROE
0%
ROCE
−0.1%
Dividend yield
0%
Debt / equity
0
Sector
Finance
Industry
Investment Company
Listed on
NSE, BSE

About

Hexa Tradex Limited is an India-based company. The Company is focused on trading in chemicals, iron & steel and related products, machinery parts and accessories, minerals, motor vehicle parts, accessories and components, non-ferrous metal & related products, old & discarded, unserviced, obsolete materials, paints, varnishes and adhesives, and others. It also acts as an import and export agent, representative, contractor, selling agent, broker on a wholesale cash and carry basis. Its trading businesses include thermal and cocking coal, copper, edible oil, zinc ingots, and more. The Company's subsidiary is Hexa Securities and Finance Company Limited.

Quick check

The five things to look at first. Open one for more.

Compared with its industry

Investment Company: 66 companies →

Hexa Tradex against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

  • Valuation (P/E)41.4 against a typical 40.7: pricier than most peers (1st = cheapest).35th of 66
  • Share price, 3 months−6% against a typical −9.4%.21st of 66
  • Size₹ 900.2 Cr. market value against a typical ₹ 171.2 Cr. (1st = largest).19th of 61

Board meetings

Results dates and other board meetings. Full calendar

Details
11 Aug 2026Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2026
11 May 2026Financial ResultsTo consider and approve the financial results for the period ended March 31, 2026
5 Feb 2026Financial ResultsTo consider and approve the financial results for the period ended December 31, 2025
12 Nov 2025Financial ResultsTo consider and approve the financial results for the period ended September 30, 2025
12 Aug 2025Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2025
27 May 2025Financial ResultsTo consider and approve the financial results for the period ended March 31, 2025

Share price

1Y change −15.91%
Volume (shares)Price (₹)
Close price

Financials

Consolidated figures in ₹ crore.

Quarterly results
₹ Cr.Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales440−4030203010
Expenses1111125−0344−2
Operating Profit340−5−12−2−300−4−32
OPM %77.7%98.1%——77.1%—−205.3%—3.9%−20,950%−191.7%—
Other Income000−308000100
Interest111111011000
Depreciation000000000000
Profit before tax238−6−415−3−0−0−4−32
Tax %16.6%23.4%−74.1%−58%4,167.9%−438.9%11.5%0%125.6%17.6%10.7%0%
Net Profit229−1−2−4626−4−0−1−4−32
EPS in Rs0.285.32−0.27−0.34−8.254.74−0.67−0.03−0.16−0.79−0.60.3

Growth and returns

Compounded yearly rates over each period.

Compounded Sales Growth
10 Years
−12%
5 Years
69%
3 Years
72%
TTM
0%
Compounded Profit Growth
10 Years
—
5 Years
—
3 Years
18%
TTM
70%
Stock Price CAGR
10 Years
25%
5 Years
−5%
3 Years
3%
TTM
—
Return on Equity
10 Years
0%
5 Years
0%
3 Years
1%
TTM
—

Shareholding

Latest: Jun 2026.

Promoters
92.13%
0 pts in a year
FIIs
0.05%
0 pts in a year
DIIs
0.04%
−0.09 pts in a year
Public
7.79%
+0.08 pts in a year

P/E and EPS over time

Daily P/E and trailing 12-month EPS. EPS updates with each result.

P/E 41.4xEPS (12 months) ₹ 3.88Median P/E 9.4x
P/E (times)EPS (₹)

Peers

Listed companies in the same business.

Peer comparison
Hexa Tradex₹ 148.00₹ 900 Cr.41.4x0.2x0%—
Bharat Forge₹ 1,709.60₹ 81,734 Cr.89.6x10.9x11.5%6.5%
Havells India₹ 1,032.00₹ 64,764 Cr.44.1x7.9x—6.9%
Schaeffler India₹ 3,468.00₹ 54,379 Cr.56.2x10.7x—12%
Sterlite Technologies₹ 829.00₹ 42,603 Cr.464.5x11.2x2.6%1.2%
R R Kabel₹ 2,150.60₹ 26,329 Cr.51.2x10.1x20.8%5.1%

Management

Pravesh Srivastava
Chief Executive Officer, Company Secretary
Pooran Singh
Chief Financial Officer

Prices are delayed and for information only. Nothing on this page is investment advice.